Literature DB >> 29675906

Angiotensin receptor signaling in sickle cell anemia has a reno-protective effect on urine concentrating ability but results in sickle glomerulopathy.

Swarnava Roy1, Parul Rai1,2, Marthe-Sandrine Eiymo Mwa Mpollo1, Kyung-Hee Chang1, Tilat Rizvi1, Shiva Kumar Shanmukhappa3, Katherine VandenHeuvel3, Bruce Aronow4, Tadashi Inagami5, Jose A Cancelas1,6, Punam Malik1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29675906      PMCID： PMC6037553          DOI： 10.1002/ajh.25118

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  6 in total

1.  AT1 receptors in the collecting duct directly modulate the concentration of urine.

Authors:  Johannes Stegbauer; Susan B Gurley; Matthew A Sparks; Magdalena Woznowski; Donald E Kohan; Ming Yan; Ruediger W Lehrich; Thomas M Coffman
Journal:  J Am Soc Nephrol       Date:  2011-11-03       Impact factor: 10.121

Review 2.  AT2 receptors in cardiovascular and renal diseases.

Authors:  Elena Kaschina; Pawel Namsolleck; Thomas Unger
Journal:  Pharmacol Res       Date:  2017-07-08       Impact factor: 7.658

Review 3.  TGF-β/Smad signaling in kidney disease.

Authors:  Hui Y Lan; Arthur C-K Chung
Journal:  Semin Nephrol       Date:  2012-05       Impact factor: 5.299

Review 4.  Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.

Authors:  Barbara P Yawn; George R Buchanan; Araba N Afenyi-Annan; Samir K Ballas; Kathryn L Hassell; Andra H James; Lanetta Jordan; Sophie M Lanzkron; Richard Lottenberg; William J Savage; Paula J Tanabe; Russell E Ware; M Hassan Murad; Jonathan C Goldsmith; Eduardo Ortiz; Robinson Fulwood; Ann Horton; Joylene John-Sowah
Journal:  JAMA       Date:  2014-09-10       Impact factor: 56.272

Review 5.  Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.

Authors:  Teguh H Sasongko; Srikanth Nagalla; Samir K Ballas
Journal:  Cochrane Database Syst Rev       Date:  2015-06-04

6.  Vasculopathy-associated hyperangiotensinemia mobilizes haematopoietic stem cells/progenitors through endothelial AT₂R and cytoskeletal dysregulation.

Authors:  Kyung Hee Chang; Ramesh C Nayak; Swarnava Roy; Ajay Perumbeti; Ashley M Wellendorf; Katie Y Bezold; Megan Pirman; Sarah E Hill; Joseph Starnes; Anastacia Loberg; Xuan Zhou; Tadashi Inagami; Yi Zheng; Punam Malik; Jose A Cancelas
Journal:  Nat Commun       Date:  2015-01-09       Impact factor: 14.919
  6 in total
  9 in total

1.  Elimination of the fibrinogen integrin αMβ2-binding motif improves renal pathology in mice with sickle cell anemia.

Authors:  Md Nasimuzzaman; Paritha I Arumugam; Eric S Mullins; Jeanne M James; Katherine VandenHeuvel; Marilou G Narciso; Maureen A Shaw; Sarah McGraw; Bruce J Aronow; Punam Malik
Journal:  Blood Adv       Date:  2019-05-14

Review 2.  The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target.

Authors:  U Muscha Steckelings; Robert E Widdop; Edward D Sturrock; Lizelle Lubbe; Tahir Hussain; Elena Kaschina; Thomas Unger; Anders Hallberg; Robert M Carey; Colin Sumners
Journal:  Pharmacol Rev       Date:  2022-10       Impact factor: 18.923

3.  ATR1 Angiotensin II Receptor Reduces Hemoglobin S Polymerization, Phosphatidylserine Exposure, and Increases Deformability of Sickle Cell Disease Erythrocytes.

Authors:  Camila Cristina Guimarães-Nobre; Evelyn Mendonça-Reis; Lyzes Rosa Teixeira-Alves; Leandro Miranda-Alves; Clemilson Berto-Junior
Journal:  Cell Biochem Biophys       Date:  2022-09-29       Impact factor: 2.989

Review 4.  The nephropathy of sickle cell trait and sickle cell disease.

Authors:  Kenneth I Ataga; Santosh L Saraf; Vimal K Derebail
Journal:  Nat Rev Nephrol       Date:  2022-02-21       Impact factor: 42.439

5.  Progression of albuminuria in patients with sickle cell anemia: a multicenter, longitudinal study.

Authors:  Omar Niss; Adam Lane; Monika R Asnani; Marianne E Yee; Ashok Raj; Susan Creary; Courtney Fitzhugh; Prasad Bodas; Santosh L Saraf; Sharada Sarnaik; Prasad Devarajan; Punam Malik
Journal:  Blood Adv       Date:  2020-04-14

Review 6.  Sickle cell nephropathy: A review of novel biomarkers and their potential roles in early detection of renal involvement.

Authors:  Osama Y Safdar; Rana M Baghdadi; Sereen A Alahmadi; Bana E Fakieh; Amaal M Algaydi
Journal:  World J Clin Pediatr       Date:  2022-01-09

Review 7.  Cardiac pathophysiology in sickle cell disease.

Authors:  Oluwabukola Temitope Gbotosho; Michael Taylor; Punam Malik
Journal:  J Thromb Thrombolysis       Date:  2021-03-07       Impact factor: 2.300

8.  Levels of angiotensin-converting enzyme 1 and 2 in serum and urine of children with Sickle Cell Disease.

Authors:  Ho Chi Hsien; Dulce Elena Casarini; João Tomas de Abreu Carvalhaes; Fernanda Aparecida Ronchi; Lilian Caroline Gonçalves de Oliveira; Josefina Aparecida Pellegrini Braga
Journal:  J Bras Nefrol       Date:  2021 Jul-Sep

9.  Reduced blood pressure in sickle cell disease is associated with decreased angiotensin converting enzyme (ACE) activity and is not modulated by ACE inhibition.

Authors:  Pamela L Brito; Alisson F Dos Santos; Hanan Chweih; Maria E Favero; Erica M F Gotardo; Juliete A F Silva; Flavia C Leonardo; Carla F Franco-Penteado; Mariana G de Oliveira; Wilson A Ferreira; Bruna C Zaidan; Athanase Billis; Giorgio Baldanzi; Denise A Mashima; Edson Antunes; Sara T Olalla Saad; Fernando F Costa; Nicola Conran
Journal:  PLoS One       Date:  2022-02-03       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.